NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Better Protection for Transplant Recipients

That question—whether the vaccine would protect transplant patients like Keefer and others with compromised immune systems—set Dorry Segev, director of the Epidemiology Research Group in Organ Transplantation at Johns Hopkins, onto a path of scientific inquiry that has produced more than three dozen papers since February on COVID-19 vaccination in immunocompromised people and resulted in a $40 million grant from the National Institutes of Health to study the effectiveness of giving kidney transplant recipients a third vaccine dose. The first part of the COVID-19 Protection After Transplant study also aims to learn which transplant patients can benefit from a third dose and which ones may need to take a different approach, such as temporarily reducing their transplant medication dosage before vaccination.